InNexus Biotechnology (InNexus Biotechnology) EV-to-EBITDA : 0.00 (As of Jun. 22, 2024)

InNexus Biotechnology EV-to-EBITDA Chart

InNexus Biotechnology Annual Data
	Trend	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09	Jun10
EV-to-EBITDA		Get a 7-Day Free Trial					-4.01	-2.90	-2.13	-1.65	-2.42

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
EV-to-EBITDA	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of InNexus Biotechnology's EV-to-EBITDA

For the Biotechnology subindustry, InNexus Biotechnology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's EV-to-EBITDA falls into.

InNexus Biotechnology EV-to-EBITDA Calculation

InNexus Biotechnology's EV-to-EBITDA for today is calculated as:

InNexus Biotechnology's current Enterprise Value is $0.00 Mil.
InNexus Biotechnology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InNexus Biotechnology  (GREY:IXSBF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

InNexus Biotechnology's PE Ratio for today is calculated as:

InNexus Biotechnology's share price for today is $0.0001.
InNexus Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.039.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

InNexus Biotechnology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description